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We found that CEL-I, a GalNAc-specific C-type lectin isolated from the marine 
invertebrate Holothuroidea (Cucumaria echinata), induces inducible nitric oxide 
synthase (iNOS) expression and NO production in RAW264.7 cells. The NO production 
was inhibited by an iNOS inhibitor, L-NAME, but was not by a lipopolysaccharide 
(LPS) inhibitor, polymyxin B. In the presence of 0.1 M GalNAc, increased NO 
production by CEL-I-treated RAW264.7 cells was observed rather than the inhibition. 
Bovine serum albumin (BSA) significantly inhibited the CEL-I-induced NO production 
as well as the binding of FITC-labeled CEL-I on RAW264.7 cells. Three MAP kinase 
inhibitors (specific to extracellular regulated kinase, c-jun NH2-terminal kinase, and p38 
MAP kinase) inhibited CEL-I-induced NO production with different extents. 
Heat-treatment of CEL-I resulted in a decreased activity of CEL-I depending on the 
temperature. These results suggest that CEL-I induces NO production in RAW264.7 
cells through the protein-cell interaction rather than the binding to the specific 
carbohydrate chains on the cell surface.  
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(iNOS), nitric oxide (NO). 
 
Abbreviations: C-type lectin, Ca2+-dependent lectin; DMEM, Dulbecco’s modified 
Eagle’s minimal essential medium; ERK, extracellular regulated kinase; FBS, fetal 
bovine serum; FITC, fluorescein isothiocyanate; F-CEL-I, FITC-labeled CEL-I; 
GalNAc, N-acetylgalactosamine; GlcNAc, N-acetylglucosamine; G-CSF, granulocyte 
colony-stimulating factor; IFN-, interferon-; iNOS, inducible nitric oxide synthase; 
JNK, c-jun NH2-terminal kinase; L-NAME, NG-nitro-L-arginine methyl ester; LPS, 
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lipopolysaccharide; MAP kinase, mitogen-activated protein kinase; NO, nitric oxide; 
PBS, phosphate-buffered saline; PHA-L, phytohemagglutinin-L (Phaseolus vulgaris 
agglutinin); TNF, tumor necrosis factor; WGA, wheat germ agglutinin. 
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INTRODUCTION 
Lectins are a group of proteins or glycoproteins that are capable of specific recognition 
and reversible binding to carbohydrate moiety of glycoproteins or glycolipids on cell 
surface. Thus, lectins are not only interesting bioactive molecules but also useful tools 
in studies of cell surface, oligosaccharide, and glycoconjugate structures (1).  
In addition to huge numbers of plant lectins, a few lectins are also found in 
animals and microorganisms, and especially animal lectins have been studied along with 
their physiological functions (2, 3). Ca2+-dependent (C-type) and independent (galectin) 
lectins are known as major classes of animal lectins (4-6). The C-type animal lectins 
have characteristic carbohydrate-recognition domain (CRD) consisting of 120-130 
amino acids residues, which exhibits some degree of sequence homology between 
species. Several C-type lectins have been found in marine invertebrates (7-10). 
Hatakeyama et al. have isolated four Ca2+-dependent galactose/GalNAc-specific lectins 
(CEL-I, II, III, and IV) from the marine invertebrate Cucumaria echinata 
(Holothuroidea) (11). Interestingly, it has been demonstrated that one of these lectins, 
CEL-III, is a novel Ca2+-dependent lectin that exhibits potent hemolytic activity and 
cytotoxicity, and membrane damage through the formation of ion-permeable pores in 
the plasma membrane is proposed to be the underlying cytotoxic and hemolytic 
mechanisms of CEL-III (12-14). On the other hand, CEL-I is the smallest 
Ca2+-dependent lectin in C. echinata which is composed of two identical subunits of 16 
kDa linked by a single disulfide bond. CEL-I shows very high specificity for GalNAc, 
and the binding affinity of CEL-I for GalNAc is estimated to be approximately 
1000-fold higher than that for galactose (11, 15). Furthermore, previous study has 
demonstrated that CEL-I is highly cytotoxic to MDCK, HeLa, and XC cells, whereas 
CHO, L929, and RAW264.7 cells were relatively resistant (16, 17). Since neither 
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hemolytic activity nor a pore-forming property of CEL-I have been found so far, the 
cytotoxic mechanism of CEL-I seems to be different from that of CEL-III. Based on the 
dramatic cellular morphological change accompanied with an increase in membrane 
permeability in CEL-I-treated MDCK cells, it is considered that CEL-I may cause the 
profound change in the plasma membrane structure which may partly responsible for 
the cytotoxicity (17).   
In addition to the potent cytotoxicity, recent studies have demonstrated that 
CEL-I induces the secretion of TNF- and G-CSF from mouse macrophage cell line 
RAW264.7 in a dose-dependent manner (18). For the cytokine-inducing activity of 
CEL-I, the specific cell surface binding or plasma membrane attack seems to be 
important rather than endocytotic internalization and subsequent vesicle trafficking 
through the Golgi complex. The involvement of MAP kinase system in the process 
leading to cytokine secretion was also suggested (18).  
It has been reported that some lectins such as Con A, PHA (19), and mistletoe 
lectin (20) induce nitric oxide (NO) production in macrophages as well as cytokine 
secretion. NO, a gaseous free radical, is known to be one of the most important effector 
molecules of innate immune cells. NO is synthesized by three different classes of NO 
synthase: inducible NOS (iNOS), endothelial NOS (eNOS), and neuronal NOS (nNOS) 
which are involved in vasodilatation, inflammation, and immune responses (21-23). In 
macrophages, NO production is induced after inflammatory stimulation and subsequent 
expression of iNOS (24, 25). It is well documented that a stimulatory pathway in 
macrophages is initiated by binding of a bacterial cell wall component 
(lipopolysaccharide, LPS) to the CD14-toll-like receptor that triggers a complex kinase 
cascade and eventually leads to gene activation and subsequent expression of iNOS 
(26). 
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In this study, we investigated whether or not CEL-I can induce NO production in 
RAW264.7 cells. The results indicated that CEL-I was able to induce NO production 
through the activation of the iNOS gene expression.    
 
MATERIALS AND METHODS 
 
 Materials – CEL-I was purified from an aqueous extract of C. echinata by 
means of column chromatography on Lactosyl-Cellulofine, GalNAc-Cellulofine, and 
Sephadex G-75, essentially as reported previously (11, 12), and stored at -80°C until use. 
Phytohemagglutinin-L (PHA-L) was obtained from Seikagaku Co., Tokyo, Japan and 
Wheat germ agglutinin (WGA) and MTT 
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) were obtained from 
Sigma Chem. Co., St. Louis, MO, USA. Anti-mouse TNF- monoclonal antibody was 
purchased from Endogen, Inc., Boston, MA. Murine-recombinant interferon- (IFN-) 
was purchased from PharMingen Co., San Diego, CA, USA. Sulfanilic acid and 
N-1-naphtyl-ethlenediamine dihydrochloride were purchased from Wako Pure Chemical 
Industry, Co., Ltd., Osaka, Japan. Fluorescein isothiocyanate isomer I (FITC), and 
NG-nitro-L-arginine methyl ester (L-NAME), an inhibitor for NO synthase, were 
purchased from Dojin Chemical Laboratories, Kumamoto, Japan. PD98059, SB202190, 
and SP600125, which are specific inhibitors for extracellular regulated kinase (ERK), 
p38 mitogen-activated protein (MAP) kinase, and c-jun NH2-terminal kinase (JNK), 
respectively, were obtained from Calbiochem Co., La Jolla, CA, USA. 
 Cell Culture – RAW264.7 (mouse macrophage) cells were obtained from the 
American Type Culture Collection, Rockville, MD, USA, and cultured in Dulbecco’s 
modified Eagle’s minimum essential medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS), penicillin G (100 IU/ml), and streptomycin (100 g/ml) as 
described previously (18).  
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Measurement of Cytotoxicity of Lectins – Cytotoxicity of lectins on RAW264.7 
cells was measured by MTT tetrazolium cytotoxicity assay. In brief, 3 x 104 cells/well in 
a 96-well plate were cultured with varying concentrations of each lectin in the 
serum-free DMEM for 24 h, and then incubated with MTT for 20 min. After aspiration 
of the medium, dimethylsulfoxide was added to dissolve the MTT formazan reaction 
product and the optical density was measured at 535 nm using a multiwell scanning 
spectrophotometer (Multiskan Spectrum, Thermo Electron Co., Vantaa, Finland).  
 Nitrite assay for estimation of NO production – Adherent cells in 96-well plates (3 
x 104 cells/well) in serum-free DMEM were treated with CEL-I at 37℃. After the 
incubation for the indicated periods of time, NO production was determined by assaying 
the culture medium for NO2
-, the stable reaction product of nitric oxide (NO) with 
molecular oxygen using Griess reagent (3 mM sulfanilic acid, 30 M 
N-1-naphtyl-ethlenediamine dihydrochloride, 25% glacial acetic acid). The supernatants 
of cultured cells were mixed with twice volume of Griess reagent. After incubation at 
room temperature for 20 min, the absorbance at 550 nm was then measured using a 
spectrophotometer (Thermo Electron). The NO2
- concentrations were estimated from a 
reference to a standard curve for serial twofold dilution of NaNO2. 
  Western blot analysis for detection of iNOS expression – Adherent cells in 96-well 
plates (3 x 104 cells/well) in serum-free DMEM were treated with CEL-I at 37℃. After 
the incubation for the indicated periods of time, the cells were washed three times with 
ice cold PBS, and were lysed with 100 l extraction buffer (10 mM HEPES, 150 mM 
NaCl, 1 mM EGTA, 1% CHAPS, and 1% Triton X-100) containing protease inhibitor 
cocktail (Nakarai tesque Co., Kyoto, Japan). After shaking for 30 min at 4℃, the 
cytosolic fraction was obtained from the supernatant after centrifugation at 15,000 rpm 
for 10 min, and the protein concentrations were determined with the BCA assay kit 
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(Sigma) by using BSA as the standard. The extract was mixed with the equal volume of 
SDS-sample buffer (1% SDS, 1% 2-mercaptoethanol, 10 mM Tris–HCl, pH 6.8, 5% 
glycerin) and incubated at 60℃ for 30 min. Samples containing 10 g of protein were 
subjected to SDS-PAGE in a 10% polyacrylamide gel. The proteins were then 
electrotransferred to a polyvinylidene difluoride (PVDF) membrane, and the membrane 
was blocked with 1% skim milk in TBS-0.1% Tween 20 (TBST). Immunostaining of 
the blot was performed with anti-iNOS (Upstate Biotechnology, Lake Placid, NY, 
USA) and Goat anti-rabbit IgG-horseradish peroxidase conjugate (Upstate). The blot 
was developed by using ECL Plus Western Blotting Detection Reagents (Amersham 
Biosciences, Piscataway, NJ, USA).  
   RNA isolation and reverse transcription polymerase chain reaction (RT-PCR) 
for detection of iNOS mRNA expression – Adherent cells in 12 wells plates (1 x 106 
cells/well) in serum-free DMEM were treated with CEL-I at 37℃. After the incubation 
for the indicated periods of time, total RNA was isolated from the cells with Trizol 
Reagent (Invitrogen Co., Carlsbad, CA, USA). Total RNA (1 µg) was reverse 
transcribed with an oligo dT primer in a 10-µl reaction volume using PrimeScript 1st 
strand cDNA Synthesis Kit (TaKaRa, Co., Ltd., Kyoto, Japan) according to the 
manufacturer’s instructions. PCR was performed with 1 cycle of 70 sec at 95°C, 20 
cycles of 55 sec at 93°C, 45 sec at 61°C, 40 sec at 72°C, and 1 cycle of 100 sec at 72°C, 
in a 25 µl reaction mixture containing 12.5 µl of GoTaq Green Master Mix (Promega, 
Co., Madison, WI, USA), 0.5 µl of forward and reverse primers (1 µM each), 0.5 µl of 
1st strand cDNA, and 11 µl of nuclease-free water. The primer sets for iNOS, 
respectively, were synthesized as described by Imanishi et al (27). Each PCR reaction 
(25 µl) was run on 2% agarose gels containing 0.1 g/ml ethidium bromide, and the 
amplified products (231 bp for iNOS) were observed by Light capture (ATTO Co., 
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Tokyo, Japan). 
FITC Labeling of CEL-I – FITC-labeled CEL-I (F-CEL-I) was prepared by 
essentially the same method as described previously (14). In brief, 2 mg of FITC was 
added to 1 ml of 0.5 M sodium bicarbonate buffer, pH 8.3, containing 10 mg of CEL-I 
and 0.1 M GalNAc. After stirring for 4 h at 4°C, the reaction mixture was applied to a 
column (1.5 x 10 cm) of Sephadex G-25 previously equilibrated with 
phosphate-buffered saline, pH7.4 (PBS), followed by dialysis against PBS. F-CEL-I 
retained the original hemagglutinating activity toward rabbit erythrocytes and NO 
inducibility.  
Binding of FITC-Labeled CEL-I – Cell monolayers (2 x 105 cells/well of 48-well 
plates) were incubated with 25 g/ml of F-CEL-I at 37°C for 2 h in serum-free DMEM. 
After removal of the medium by aspiration, the cells were washed three times with 
ice-cold PBS. The washed cells were solubilized in 0.5 ml of 20 mM Tris-HCl buffer, 
pH 8.5, containing 0.1% SDS. The fluorescence intensity of the solubilized cell lysate 
was measured with a Hitachi F-2500 fluorescence spectrophotometer (Hitachi 
Instruments, Tokyo, Japan) at an excitation wavelength of 490 nm and an emission 
wavelength of 520 nm. 
 
RESULTS 
Cytotoxicities of CEL-I, PHA-L, and WGA on RAW264.7 cells – In our 
previous study, we found that CEL-I showed cytotoxic effects on several cell lines 
depending on the cell lines. Among the cell lines tested, RAW264.7 cells were relatively 
resistant to CEL-I cytotoxicity (17). Consistent with this, the viability of RAW264.7 
cells was more than 60% even after 24 h exposure to 100 g/ml of CEL-I. PHA-L and 
WGA also showed dose-dependent cytotoxicity on RAW264.7 cells, and the order of 
the cytotoxic potency of these lectins was WGA>PHA-L>CEL-I (Fig. 1).                           
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Induction of NO Production by CEL-I in RAW264.7 Cells – As shown in Fig. 2, 
CEL-I induced NO production in RAW264.7 cells in a concentration-dependent manner. 
Under the same conditions, PHA-L also induced the production of NO, but the level of 
NO was much lower than the levels induced by CEL-I. WGA had no such activity up to 
100 g/ml. Consistent with time-dependent increase in NO production in the 
CEL-I-treated RAW264.7 cells, increased expressions of iNOS mRNA and NOS protein 
were observed in a time-dependent manner as examined by RT-PCR and Western 
blotting, respectively (Fig. 3). 
Effects of Polymyxin B, L-NAME, and anti-TNF- antibody on 
CEL-I-Induced NO Production in RAW264.7 Cells – To confirm that CEL-I-induced 
NO production is not due to the contamination of trace amount of endotoxin in CEL-I 
sample, the effect of polymyxin B, an inhibitor for LPS, was examined. As shown in Fig. 
4A, in the presence of polymyxin B, only a slight reduction of NO production in 
CEL-I-treated RAW264.7 cells was observed, while LPS-induced NO production was 
strongly inhibited. Furthermore, to avoid the effects of polymyxin B itself, CEL-I 
solution was applied to a polymyxin B-column, and then examined the NO-inducing 
activity. More than 90% of the activity remained after having passed thought the column 
(data not shown). On the other hand, both CEL-I- and LPS-induced NO productions 
were diminished in the presence of L-NAME, a NO synthase (NOS) inhibitor, in a 
concentration-dependent manner (Fig. 4B). Since our previous study demonstrated that 
CEL-I is capable of inducing TNF- secretion from RAW264.7 cells (18), and TNF- 
is known to provoke NO production from macrophages (28), there is a possibility that 
CEL-I-induced NO production is a secondary phenomenon by the TNF- induced by 
CEL-I first. To verify this possibility, the effects of anti-TNF- antibody on the CEL-I- 
induced NO production was examined. In the presence of 10 g/ml of anti-TNF- 
antibody, no significant reduction in the NO level induced by CEL-I was observed, even 
though this concentration of anti-TNF- antibody completely prevented the detection of 
100 ng/ml of TNF-(data not shown) which is far more higher than the maximum 
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level of TNF- induced by 100 g/ml of CEL-I from RAW264.7 cells (18). 
Effect of IFN- on CEL-I- and LPS-induced NO production – It has been 
reported that synergistic enhancement of NO production is observed when RAW264.7 
cells were stimulated by LPS in combination with IFN- (29). To ascertain whether or 
not CEL-I-induced NO production by RAW264.7 cells is also influenced by IFN-, 
CEL-I-induced NO levels in the presence of varying concentrations of IFN- were 
examined. As shown in Fig. 5, IFN- enhanced CEL-I-induced NO levels in a 
concentration-dependent manner as seen in LPS-stimulated RAW264.7 cells. In both 
cases, the maximum synergistic effect was attained at 1,000 U/ml of IFN-. 
Effects of various saccharides on CEL-I-Induced NO Production in RAW264.7 
Cells – Previous studies have demonstrated that the biological activities of CEL-I were 
inhibited by GalNAc with different extents depending on the activities. To investigate if 
the specific binding of CEL-I on the macrophage cell surface saccharide chains is 
involved in the NO production, the effects of GalNAc and other saccharides were 
examined at the molar ratio of nearly 100,000:1 between saccharide and CEL-I. 
Unexpectedly, in the presence of GalNAc (0.1 M), increased NO production in 
CEL-I-treated RAW264.7 cells was observed rather than the inhibition. The effect of 
GalNAc was dose-dependent, and even 0.01 M GalNAc showed a slight enhancement 
effect (data not shown). Other monossacharides such as glucose, GlcNAc, mannose, and 
galactose also showed similar enhancement effects. The enhancement of NO production 
by these saccharides was also observed in LPS or PHA-L induced NO production (Fig. 
6).   
Effects of BSA on CEL-I-Induced NO Production in RAW264.7 Cells and on 
the Binding of FITC-labeled CEL-I to RAW264.7 Cells – To gain insight into the 
involvement of protein-cell interaction in the CEL-I-induced NO production in 
RAW264.7 cells, the effect of BSA as a typical inert protein was examined. As shown in 
Fig. 7A, BSA inhibited the CEL-I-induced NO production. Furthermore, the binding of 
FITC-labeled CEL-I to RAW264.7 cells was also inhibited by BSA (Fig. 7B).  
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Effects of MAP Kinase inhibitors on the CEL-I-Induced NO production – 
To investigate the involvement of MAP kinase system in the CEL-I-induced 
NO production in RAW264.7 cells, the effects of the specific inhibitors for ERK 
(PD98059), p38 (SB202190), and JNK (SP600125) MAP kinase were examined. As 
shown in Table I, these inhibitors showed the inhibitory effects with different extents, 
and, and ERK inhibitor was the most effective. 
 Effects of Heat-Treatment of CEL-I on the NO-inducing Activity in RAW264.7 
Cells – After the treatment of CEL-I at various temperatures (37-100°C) for 15 min, the 
NO-inducing activity of CEL-I was examined (Table II). The activity decreased 
depending on the temperature. After 15 min treatment at 100°C, the activity decreased 




Our previous studies have demonstrated that CEL-I stimulates RAW264.7 cells 
to produce high level of cytokines such as TNF- and G-CSF. In the present study, we 
found that CEL-I also induces the production of NO in RAW264.7 cells at no 
significant cytotoxic concentration range. The increased NO production by RAW264.7 
cells in response to CEL-I was concentration- and time-dependent. Since only a slight 
inhibitory effect of polymyxin B, an inhibitor of LPS, on the CEL-I-induced NO 
production was observed, CEL-I itself is responsible for the activity. Furthermore, 
anti-TNF- antibody had almost no effect on the NO level induced by CEL-I. Thus it 
seems likely that the direct effect of CEL-I on RAW264.7 cells is mainly responsible for 
the induction of NO production. Since both CEL-I- and LPS- induced NO production 
were synergistically enhanced by IFN-, IFN--mediated signaling may be involved in 
the action of CEL-I and LPS leading to eventual NO production as a common pathway.  
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The presence of an inducible pathway for NO production from L-arginine 
catalyzed by inducible NO synthase (iNOS) has been well documented in monocytes 
and macrophages in response to cytokines and LPS (30, 31). In fact, CEL-I-induced NO 
production in RAW264.7 cells was inhibited by L-arginine analog NOS inhibitor 
L-NAME in a concentration-dependent manner as seen in LPS-induced NO production. 
Furthermore, increases in the expression of iNOS mRNA and iNOS protein were 
observed in CEL-I-treated cells along with the incubation time.  
Thus far, few investigations have shown the effects of lectins on NO 
production. It has been reported that Con A and PHA but not WGA induced increased 
NO production in mouse peritoneal macrophages in dose- and time-dependent manners 
(19). Similar to CEL-I observed in this study, it has been shown that Con A and PHA 
treatment of macrophages induced transcription of iNOS gene and the enhanced 
expression of iNOS protein. A glucose/mannose-specific lectin isolated from emperor 
banana has been reported to induce NO production by mouse peritoneal macrophages 
(32). On the other hand, it has been reported that galectin-1 elicited a dose- and 
time-dependent inhibition of LPS-induced NO production, accompanied by a decrease 
in iNOS expression (33). Although the exact mechanisms of lectin-induced NO 
production including the case of CEL-I are still unclear, these findings suggest that the 
specific biochemical characteristics of lectin molecules are important for the effects of 
lectin on macrophages in terms of the induction of NO production rather than the simple 
carbohydrate recognition specificity. 
Unexpectedly, in the presence of GalNAc, an increase in NO level in 
CEL-I-treated cells was observed rather than the inhibitory effect, even though 0.1 M 
GalNAc inhibited the other biological activities of CEL-I such as hemagglutination (16), 
cytotoxicity (17), and induction of cytokine secretion (18). The exact reason for the 
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inability of GalNAc to inhibit the CEL-I-induced NO production is unknown now, but 
one possible speculation is that still unknown functional sites on CEL-I molecule apart 
from the carbohydrate-recognition sites are involved in the induction of NO production. 
In general, lectins exert certain biological activities through the recognition of the 
specific carbohydrate moieties on the target cell surface. However, there are severl lines 
of evidence as well as speculation in favor of non-carbohydrate lectin interaction with 
cell surface molecules (34, 35). For instance, it has been reported that heat denatured 
Abrus agglutinin, which lost any sugar binding activity, acted as an adjuvant to induce 
antigen specific humoral immune response in rat (36) and also stimulated murine 
peritoneal macrophages to release NO, superoxide anion, IL-1, and TNF (37). Further 
studies have demonstrated that Abrus agglutinin on heart denaturation lost its 
carbohydrate binding activity, but it could still exert the immunomodulating activities 
(38). In addition, it has been reported that both the A and the B chains, the constituent 
subunits of Korean mistletoe lectin, induced macrophage-mediated NO production 
much greater than hololectin, even though the A chain has no carbohydrate binding 
activity (20). In the case of CEL-I-induced NO production, CEL-I may be recognized 
by RAW264.7 cells through the specific protein moieties of CEL-I molecule apart from 
the binding of CEL-I on the carbohydrate chains on the cell surface. The inhibitory 
effect of BSA on CEL-I-induced NO production as well as on the binding of 
FITC-labeled CEL-I on RAW264.7 cells may support this notion. Although the effective 
concentration is quite higher than that of CEL-I, BSA has been reported to induce NO 
production from macrophages (39). Thus macrophages may have specific recognition 
sites for certain structures of BSA, which can be linked with the intracellular signaling 
pathway leading to NO production. Probably, BSA and CEL-I may compete such 
recognition sits on RAW264.7 cells each other. Since the heat-treatment of CEL-I 
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resulted in the significant decrease in the activity to induce NO production in 
RAW264.7 cells depending on the temperature, the intact conformation of CEL-I may 
be necessary for such specific interaction of CEL-I with the cell surface. As revealed by 
X-ray crystallographic analysis (40), CEL-I is composed of homodimer of the C-type 
carbohydrate-recognition domains (5), each of which contains a carbohydrate-binding 
site at its outward end. Because the specific sugars, such as GalNAc, did not inhibit the 
NO production, the interaction with RAW264.7 cell surface might be mediated by the 
lateral face of CEL-I. In fact, CEL-I has a dumbbell-like shape with some shallow 
pockets around its middle portion, which might be involved in interaction with the 
target molecules on the cell surface. Further studies are required to clarify this point 
especially from the viewpoint of structure-activity relationship of CEL-I. 
In addition to GalNAc, Glucose, GlcNAc, Galactose, and Mannose also 
showed enhancement effects on CEL-I-induced NO production. Furthermore, similar 
enhancement effects of these monosaccharides were observed in LPS- and PHA-L- 
induced NO productions. It has been reported that LPS-induced iNOS gene expression 
in rat glial cells was enhanced by extracellular glucose concentration in a 
dose-dependent manner, and had suggested that glucose metabolism is linked to the 
regulation of iNOS gene expression (41). Therefore, GalNAc and other 
monosaccharides may influence the glucose metabolism which in turn leads to the 
increase in NO production via the enhancement of iNOS gene expression.    
It has been demonstrated that protein phospholylation mediated by tyrosine 
kinase and the serine/threonine are correlated with the production of NO in 
macrophages activated by LPS and interleukins (31). Based on the analysis using 
various specific inhibitors, it has been suggested that in addition to the common 
pathways, Con A and PHA may stimulate their own specific signaling pathway leading 
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to NO production in macrophages. Namely, p38 MAP kinase is mainly involved in Con 
A, whereas JNK MAPK is involved in PHA induced NO production (19). Our previous 
study using Bio-Plex beads assay has suggested that temporal increase in 
phosphorylation of extracellular regulated kinase (ERK), c-jun NH2-terminal kinase 
(JNK), and p38 MAP kinase occurred at relatively early time following CEL-I treatment 
in RAW264.7 cells, and the CEL-I-induced cytokine secretion was inhibited by specific 
inhibitors for these MAP kinases (18). Among the three MAP kinase inhibitors, ERK 
inhibitor showed the most potent inhibitory effect on CEL-I-induced NO production. 
Thus it seems likely that CEL-I and PHA may use similar MAP kinase pathway leading 
to NO production in which ERK kinase may play a key role in common.     
In conclusion, we found that CEL-I induced NO production in RAW264.7 cells 
through the increase in iNOS gene expression. The exact mechanism of CEL-I is still 
unknown, but non-carbohydrate CEL-I interaction with macrophage cell surface may be 
responsible for the activity rather than the simple binding of CEL-I on carbohydrate 
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Fig. 1. Cytotoxicities of CEL-I ( ), PHA-L (○), and WGA ( ) on RAW264.7 cells. 
Adherent cells (3 x 104 cells/well in 96-well plates) were treated with various 
concentrations of each lectin in serum-free DMEM at 37°C. After 24 h, the cell 
viabilities were measured by MTT assay as described under "MATERIALS AND 
METHODS". Each point represents the average of triplicate measurements. 
 
Fig. 2. NO production by RAW264.7 cells treated with various concentrations of 
CEL-I ( ), PHA-L (○), and WGA ( ). Adherent cells (3 x 104 cells/well in 96-well 
plates) were treated with the indicated concentration of each lectin in serum-free 
DMEM at 37°C. After 24 h, the NO level in the supernatant of the cells treated under 
each condition was measured as described under "MATERIALS AND METHODS". 
Each point represents the average of triplicate measurements. 
 
 
Fig. 3.  Time course analysis of NO production (A), expression of iNOS protein 
(B), and expression of iNOS mRNA (C) in CEL-I-treated RAW264.7 cells. (A) 
Adherent cells (3 x 104 cells/well in 96-well plates) were incubated with 25 g/ml of 
CEL-I for the indicated periods of time, and then the supernatant was withdrawn from 
each well and subjected to the measurement of NO level, and the cells were subjected to 
the analysis of iNOS protein (B) as described under "MATERIALS AND METHODS". 
Each point represents the average of triplicate measurements. Adherent cells (1 x 106 
cells/ well in 12-well plates) were incubated with 25 g/ml of CEL-I for the indicated 
periods of time, and then the cells were subjected to the analysis of iNOS mRNA levels 




Fig. 4.  Effects of polymyxin B (A) and L-NAME (B) on CEL-I- and LPS-induced 
NO production in RAW264.7 cells. Adherent cells (3 x 104 cells/well in 96-well 
plates) were pre-incubated in the presence of indicated concentrations of polymyxin B 
(A) or L-NAME (B) in serum-free DMEM at 37°C for 10 min, followed by the addition 
of CEL-I (●) (final 25 g/ml) or LPS (△) (final 1 ng/ml). After 24 h incubation at 
37°C, the NO level in the supernatant of the cells treated under each condition was 
measured as described under "MATERIALS AND METHODS". Each point represents 
the average of triplicate measurements.  
 
Fig. 5.  Effects of INF- on CEL-I- and LPS-induced NO production in RAW264.7 
cells. Adherent cells (3 x 104 cells/well in 96-well plates) were treated with CEL-I (■) 
(final 25 g/ml), LPS (□) (final 1 ng/ml) or only DMEM ( ) in the presence of the 
indicated concentrations of IFN- in serum-free DMEM at 37°C for 24 h, and then the 
NO level in the supernatant of the cells treated under each condition was measured as 
described under "MATERIALS AND METHODS". Each point represents the average 
of triplicate measurements. 
 
 
Fig. 6.  Effects of GalNAc, Glucose, GlcNAc, Galactose, and Mannose on CEL-I- 
(A), PHA-L- (B) and LPS- (C) induced NO production in RAW264.7 cells. Adherent 
cells (3 x 104 cells/well in 96-well plates) were treated with CEL-I (final 25 g/ml), 
PHA-L (final 100 g/ml) or LPS (final 1 ng/ml) in the presence (□) or absence (■) of 
each saccharide (final 0.1 M) in serum-free DMEM at 37°C for 24 h, and then the NO 
level in the supernatant of the cells treated under each condition was measured as 
described under "MATERIALS AND METHODS". Each point represents the average 
of triplicate measurements. 
 
Fig. 7.  Effects of BSA on the CEL-I- and LPS-induced NO production in 
 25
RAW264.7 cells and on the binding of FITC-labeled CEL-I on RAW264.7 cells. (A) 
Adherent cells (3 x 104 cells/well in 96-well plates) were treated with CEL-I (■) (final 
25 g/ml) or LPS (□) (final 1 ng/ml) in the presence of the indicated concentrations of 
BSA in serum-free DMEM at 37°C for 24 h, and then the NO level in the supernatant of 
the cells treated under each condition was measured as described under "MATERIALS 
AND METHODS". Each point represents the average of triplicate measurements. (B) 
Adherent cells (2 x 105 cells/well in 48-well plates) were incubated with FITC-labeled 
CEL-I (final 25 g/ml) in the presence of the indicated concentrations of BSA for 2 h at 
37°C in serum-free DMEM. After incubation, the cells were washed three times with 
PBS and then the amount of cell-associated FITC-labeled CEL-I was measured as 
described under " MATERIALS AND METHODS ". Each point represents the average 
of triplicate measurements 
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Table Ⅰ . Effects of MAP kinase inhibitors on CEL-I-induced NO secretion by 
RAW264.7 cells.  
 
   Inhibitor       Level of NO2
- (% of control)a         
   PD 98059            34±1.4 
   SB 202195           60±3.2 
   SP 600125           45±5.9   
 
Adherent cells (3 x 104 cells/well in 96-well plates) were pre-incubated in the presence 
or absence of each inhibitor (final 20 mM) in serum-free DMEM at 37°C for 1 h, 
followed by the addition of CEL-I (final 25 g/ml). After 24 h incubation at 37°C, NO 
level in the supernatant of the cells treated under each condition was measured as 
described under "MATERIALS AND METHODS". Each value represents the average 
of triplicate measurements. 
a 100 % level of NO detected in the culture supernatant of CEL-I-treated RAW264.7 
cells was 42.1±0.1 M . 
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Table Ⅱ. Effects of heat-treatment on the NO-inducing activity of CEL-I in RAW264.7 
cells. 
 
  Temperature (℃)      Level of NO2
- (% of control)a         
    70                      62±1.7 
   80                      50±2.7 
   90                      50±0.1 
   100                      31±1.2 
 
CEL-I in PBS (final 1mg/ml) was treated for 15 min at the indicated temperature, and 
then the NO-inducing activity of each treated CEL-I (final 25 g/ml) was measured as 
described in the legend of Fig. 2. Each value represents the average of triplicate 
measurements. 
a 100 % level of NO detected in the culture supernatant of CEL-I-treated RAW264.7 
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